Context: One of the world's largest pharmaceutical companies with 2,000+ active clinical studies spanning 35,000 sites and medical centers globally.
Challenge: Required a robust fraud detection framework to identify data fabrication, ensure data integrity, and support regulatory submissions and patient safety decisions.
Solution: Designed and executed a comprehensive statistical fraud detection framework applying multiple methods:
Outcome: Flagged statistically significant anomalies across 2,000+ studies, with findings escalated through regulatory compliance processes. Directly informed regulatory submissions and patient safety decisions.